Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Sagimet Biosciences Inc Series A (SGMT)

Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Sagimet Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Tue Nov 26, 7:00AM CST

SGMT : 5.08 (+2.83%)
Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD - The Liver Meeting® 2024 GlobeNewswire - Mon Nov 18, 7:00AM CST

SGMT : 5.08 (+2.83%)
Sagimet Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates GlobeNewswire - Thu Nov 14, 7:00AM CST

SGMT : 5.08 (+2.83%)
Sagimet Biosciences to Participate in the UBS Global Healthcare Conference GlobeNewswire - Thu Nov 7, 6:30AM CST

SGMT : 5.08 (+2.83%)
Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024 GlobeNewswire - Tue Oct 29, 6:00AM CDT

SGMT : 5.08 (+2.83%)
Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024 GlobeNewswire - Wed Oct 16, 6:00AM CDT

SGMT : 5.08 (+2.83%)
Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology GlobeNewswire - Fri Oct 11, 6:00AM CDT

SGMT : 5.08 (+2.83%)
SGMT Stock Up 12.6% on FDA Fast Track for Liver Disease Drug
SGMT Stock Up 12.6% on FDA Fast Track for Liver Disease Drug Zacks Investment Research - Wed Oct 2, 3:08PM CDT

Sagimet Biosciences’ SGMT stock rose 12.6% on Tuesday after it announced that the FDA has granted breakthrough therapy designation (“BTD”) to its lead pipeline candidate, denifanstat, for treating...

VKTX : 42.68 (+0.78%)
MDGL : 314.04 (+0.65%)
AKRO : 28.89 (+1.16%)
SGMT : 5.08 (+2.83%)
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? Motley Fool - Sun Mar 17, 4:50AM CDT

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 0.8701 (+3.51%)
GLMD : 3.12 (+2.63%)
VKTX : 42.68 (+0.78%)
ETNB : 8.01 (+0.88%)
IVA : 2.24 (+1.81%)
SGMT : 5.08 (+2.83%)
TERN : 5.88 (+1.38%)
NVO : 87.65 (+0.32%)
IQV : 200.25 (+0.13%)
MDGL : 314.04 (+0.65%)

Barchart Exclusives

Bearish on the Market? 2 Defensive Stocks for Maximum Portfolio Protection. Barchart - 27 minutes ago
As economic growth is anticipated to slow, UBS highlights these two dividend-paying defensive stocks as smart picks, shifting focus away from cyclical stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot